The Alzheimer’s therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia Nat Neurosci (2025). DOI: 10.1038/s41593-025-02125-8 Albertini, G., Zielonka, M., Cuypers, ML. et al. (2025)
Nat Neurosci (2025). DOI: 10.1038/s41593-025-02125-8
